Rye Brook Capital’s JP Morgan Alerian MLP Index ETN 5/24/24 AMJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-273,500
Closed -$5.72M 33
2022
Q1
$5.72M Sell
273,500
-53,500
-16% -$1.07M 2.26% 10
2021
Q4
$5.82M Buy
327,000
+110,200
+51% +$2.04M 1.49% 10
2021
Q3
$3.94M Hold
216,800
2.77% 14
2021
Q2
$4.26M Hold
216,800
3.01% 12
2021
Q1
$3.6M Buy
216,800
+25,500
+13% +$405K 2.62% 14
2020
Q4
$2.66M Buy
+191,300
New +$2.49M 2.31% 15

Other funds holding AMJ

Rye Brook Capital's AMJ Position: Q2 2022 in Review

Rye Brook Capital sold out of JP Morgan Alerian MLP Index ETN 5/24/24 (AMJ) in Q2 2022, closing a stake of 273,500 shares — an estimated $5.72M sold.

Rye Brook Capital first reported a position in AMJ in Q4 2020 and held it in 6 quarters. The position peaked at $5.82M in Q4 2021. 178 funds tracked by Wall St. Rank hold AMJ as of Q2 2022.

  • Rye Brook Capital reported no remaining JP Morgan Alerian MLP Index ETN 5/24/24 position as of Q2 2022 after selling out during the quarter.
  • Rye Brook Capital sold 273,500 JP Morgan Alerian MLP Index ETN 5/24/24 shares in Q2 2022, an estimated $5.72M.
  • Rye Brook Capital first reported a position in JP Morgan Alerian MLP Index ETN 5/24/24 in Q4 2020 and held it in 6 quarters.
  • Rye Brook Capital's JP Morgan Alerian MLP Index ETN 5/24/24 position peaked at $5.82M in Q4 2021.
  • 178 funds tracked by Wall St. Rank held JP Morgan Alerian MLP Index ETN 5/24/24 as of Q2 2022.

Based on Rye Brook Capital's 13F filing for Q2 2022, filed 21 Jul 2022.